CIBC Private Wealth Group
KYNB

CIBC Private Wealth Group’s Kyntra Bio KYNB Stock Holding History

CIBC Private Wealth Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.52K Hold
287
– – ﹤0.01% 2766
2025
Q3 		$3.52K Hold
287
– – ﹤0.01% 2636
2025
Q2 		$1.52K Hold
287
– – ﹤0.01% 2702
2025
Q1 		$1.81K Hold
287
– – ﹤0.01% 2708
2024
Q4 		$4.67K Hold
287
– – ﹤0.01% 2491
2024
Q3 		$2.87K Hold
287
– – ﹤0.01% 2743
2024
Q2 		$5.81K Hold
287
– – ﹤0.01% 2473
2024
Q1 		$16.9K Buy
+287
New +$12.4K ﹤0.01% 2101
2021
Q2 		– Sell
-288
Closed -$250K – 1038
2021
Q1 		$250K Buy
288
+1
+0.3% +$1.06K ﹤0.01% 949
2020
Q4 		$266K Hold
287
– – ﹤0.01% 892
2020
Q3 		$295K Buy
+287
New +$309K ﹤0.01% 785
2020
Q2 		– Sell
-287
Closed -$249K – 664
2020
Q1 		$249K Buy
+287
New +$285K ﹤0.01% 758

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

CIBC Private Wealth Group's KYNB Position: Q4 2025 in Review

CIBC Private Wealth Group held its Kyntra Bio (KYNB) position steady in Q4 2025 at 287 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

CIBC Private Wealth Group first reported a position in KYNB in Q1 2020 and has held it in 12 quarters since. The position peaked at $295K in Q3 2020. 34 funds tracked by Wall St. Rank hold KYNB as of Q4 2025.

  • CIBC Private Wealth Group held 287 shares of Kyntra Bio worth $2.52K as of Q4 2025.
  • CIBC Private Wealth Group left its Kyntra Bio share count unchanged in Q4 2025.
  • Kyntra Bio made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2766 holding.
  • CIBC Private Wealth Group first reported a position in Kyntra Bio in Q1 2020 and has held it in 12 quarters since.
  • CIBC Private Wealth Group's Kyntra Bio position peaked at $295K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.